Literature DB >> 3042624

Current status--meningococcal vaccine.

R Merchant, R Divekar.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3042624     DOI： 10.1007/BF02722193

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  11 in total

Review 1.  Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future.

Authors:  J B Robbins
Journal:  Immunochemistry       Date:  1978-11

2.  A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.

Authors:  M H Wahdan; S A Sallam; M N Hassan; A Abdel Gawad; A S Rakha; J E Sippel; R Hablas; W R Sanborn; N M Kassem; S M Riad; B Cvjetanović
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

3.  Response of children to Neisseria meningitidis polysaccharide vaccines.

Authors:  A S Monto; B L Brandt; M S Artenstein
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

4.  Prevention of meningococcal disease by group C polysaccharide vaccine.

Authors:  M S Artenstein; R Gold; J G Zimmerly; F A Wyle; H Schneider; C Harkins
Journal:  N Engl J Med       Date:  1970-02-19       Impact factor: 91.245

5.  Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.

Authors:  W D Zollinger; R E Mandrell; J M Griffiss; P Altieri; S Berman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

6.  Meningococcal disease and season in sub-Saharan Africa.

Authors:  B M Greenwood; I S Blakebrough; A K Bradley; S Wali; H C Whittle
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

7.  Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.

Authors:  H Peltola; H Mäkelä; H Käyhty; H Jousimies; E Herva; K Hällström; A Sivonen; O V Renkonen; O Pettay; V Karanko; P Ahvonen; S Sarna
Journal:  N Engl J Med       Date:  1977-09-29       Impact factor: 91.245

Review 8.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

9.  Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

10.  PREPARATION OF THE TYPE-SPECIFIC POLYSACCHARIDE OF THE TYPE I MENINGOCOCCUS AND A STUDY OF ITS EFFECTIVENESS AS AN ANTIGEN IN HUMAN BEINGS.

Authors:  E A Kabat; H Kaiser; H Sikorski
Journal:  J Exp Med       Date:  1944-10-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.